These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 10201825)
1. Solid-phase synthesis of benzisothiazolones as serine protease inhibitors. Yu KL; Civiello R; Roberts DG; Seiler SM; Meanwell NA Bioorg Med Chem Lett; 1999 Mar; 9(5):663-6. PubMed ID: 10201825 [TBL] [Abstract][Full Text] [Related]
2. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase. Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554 [TBL] [Abstract][Full Text] [Related]
3. Potent, small-molecule inhibitors of human mast cell tryptase. Antiasthmatic action of a dipeptide-based transition-state analogue containing a benzothiazole ketone. Costanzo MJ; Yabut SC; Almond HR; Andrade-Gordon P; Corcoran TW; De Garavilla L; Kauffman JA; Abraham WM; Recacha R; Chattopadhyay D; Maryanoff BE J Med Chem; 2003 Aug; 46(18):3865-76. PubMed ID: 12930148 [TBL] [Abstract][Full Text] [Related]
4. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases. Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase. Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362 [TBL] [Abstract][Full Text] [Related]
6. Inhibitors of tryptase for the treatment of mast cell-mediated diseases. Rice KD; Tanaka RD; Katz BA; Numerof RP; Moore WR Curr Pharm Des; 1998 Oct; 4(5):381-96. PubMed ID: 10197050 [TBL] [Abstract][Full Text] [Related]
7. Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors. Rice KD; Gangloff AR; Kuo EY; Dener JM; Wang VR; Lum R; Newcomb WS; Havel C; Putnam D; Cregar L; Wong M; Warne RL Bioorg Med Chem Lett; 2000 Oct; 10(20):2357-60. PubMed ID: 11055355 [TBL] [Abstract][Full Text] [Related]
8. Mast cell tryptase: a new target for therapeutic intervention in asthma. Tanaka RD; Clark JM; Warne RL; Abraham WM; Moore WR Int Arch Allergy Immunol; 1995; 107(1-3):408-9. PubMed ID: 7613193 [No Abstract] [Full Text] [Related]
9. Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract. Hochstrasser K; Gebhard W; Albrecht G; Rasp G; Kastenbauer E Eur Arch Otorhinolaryngol; 1993; 249(8):455-8. PubMed ID: 8442939 [TBL] [Abstract][Full Text] [Related]
10. Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics. Ogbu CO; Qabar MN; Boatman PD; Urban J; Meara JP; Ferguson MD; Tulinsky J; Lum C; Babu S; Blaskovich MA; Nakanishi H; Ruan F; Cao B; Minarik R; Little T; Nelson S; Nguyen M; Gall A; Kahn M Bioorg Med Chem Lett; 1998 Sep; 8(17):2321-6. PubMed ID: 9873535 [TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of human mast cell tryptase by gabexate mesylate, an antiproteinase drug. Erba F; Fiorucci L; Pascarella S; Menegatti E; Ascenzi P; Ascoli F Biochem Pharmacol; 2001 Feb; 61(3):271-6. PubMed ID: 11172730 [TBL] [Abstract][Full Text] [Related]
12. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. He S; Gaça MD; Walls AF Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human mast cell tryptase by benzamidine derivatives. Stürzebecher J; Prasa D; Sommerhoff CP Biol Chem Hoppe Seyler; 1992 Oct; 373(10):1025-30. PubMed ID: 1418674 [TBL] [Abstract][Full Text] [Related]
14. Syntheses and evaluation of amidinobenzofuran derivatives as tryptase inhibitors. Ono S; Kuwahara S; Takeuchi M; Sakashita H; Naito Y; Kondo T Bioorg Med Chem Lett; 1999 Dec; 9(23):3285-90. PubMed ID: 10612586 [TBL] [Abstract][Full Text] [Related]
15. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase. Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of potent and selective 2-azepanone inhibitors of human tryptase. Zhao G; Bolton SA; Kwon C; Hartl KS; Seiler SM; Slusarchyk WA; Sutton JC; Bisacchi GS Bioorg Med Chem Lett; 2004 Jan; 14(2):309-12. PubMed ID: 14698147 [TBL] [Abstract][Full Text] [Related]
17. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G. Maryanoff BE J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180 [No Abstract] [Full Text] [Related]
18. Polycationic peptides as inhibitors of mast cell serine proteases. Lundequist A; Juliano MA; Juliano L; Pejler G Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological activity of a targeted library of potential tryptase inhibitors. García M; del Rio X; Silvestre S; Rubiralta M; Lozoya E; Segarra V; Fernández D; Miralpeix M; Aparici M; Diez A Org Biomol Chem; 2004 Jun; 2(11):1633-42. PubMed ID: 15162216 [TBL] [Abstract][Full Text] [Related]
20. The human mast cell tryptase tetramer: a fascinating riddle solved by structure. Sommerhoff CP; Bode W; Matschiner G; Bergner A; Fritz H Biochim Biophys Acta; 2000 Mar; 1477(1-2):75-89. PubMed ID: 10708850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]